192 related articles for article (PubMed ID: 16570050)
1. Expression of ADAMTS-8, a secreted protease with antiangiogenic properties, is downregulated in brain tumours.
Dunn JR; Reed JE; du Plessis DG; Shaw EJ; Reeves P; Gee AL; Warnke P; Walker C
Br J Cancer; 2006 Apr; 94(8):1186-93. PubMed ID: 16570050
[TBL] [Abstract][Full Text] [Related]
2. Expression of cellular adhesion molecule 'OPCML' is down-regulated in gliomas and other brain tumours.
Reed JE; Dunn JR; du Plessis DG; Shaw EJ; Reeves P; Gee AL; Warnke PC; Sellar GC; Moss DJ; Walker C
Neuropathol Appl Neurobiol; 2007 Feb; 33(1):77-85. PubMed ID: 17239010
[TBL] [Abstract][Full Text] [Related]
3. ADAMTS expression in colorectal cancer.
Filou S; Korpetinou A; Kyriakopoulou D; Bounias D; Stavropoulos M; Ravazoula P; Papachristou DJ; Theocharis AD; Vynios DH
PLoS One; 2015; 10(3):e0121209. PubMed ID: 25786261
[TBL] [Abstract][Full Text] [Related]
4. Human glioblastomas overexpress ADAMTS-5 that degrades brevican.
Nakada M; Miyamori H; Kita D; Takahashi T; Yamashita J; Sato H; Miura R; Yamaguchi Y; Okada Y
Acta Neuropathol; 2005 Sep; 110(3):239-46. PubMed ID: 16133547
[TBL] [Abstract][Full Text] [Related]
5. Expression of a disintegrin and metalloprotease (ADAM and ADAMTS) enzymes in human non-small-cell lung carcinomas (NSCLC).
Rocks N; Paulissen G; Quesada Calvo F; Polette M; Gueders M; Munaut C; Foidart JM; Noel A; Birembaut P; Cataldo D
Br J Cancer; 2006 Mar; 94(5):724-30. PubMed ID: 16495931
[TBL] [Abstract][Full Text] [Related]
6. Anti-angiogenic properties of ADAMTS-4 in vitro.
Hsu YP; Staton CA; Cross N; Buttle DJ
Int J Exp Pathol; 2012 Feb; 93(1):70-7. PubMed ID: 22264287
[TBL] [Abstract][Full Text] [Related]
7. ADAMTS-1 and -4 are up-regulated following transient middle cerebral artery occlusion in the rat and their expression is modulated by TNF in cultured astrocytes.
Cross AK; Haddock G; Stock CJ; Allan S; Surr J; Bunning RA; Buttle DJ; Woodroofe MN
Brain Res; 2006 May; 1088(1):19-30. PubMed ID: 16630594
[TBL] [Abstract][Full Text] [Related]
8. Expression of ADAMs and their inhibitors in sputum from patients with asthma.
Paulissen G; Rocks N; Quesada-Calvo F; Gosset P; Foidart JM; Noel A; Louis R; Cataldo DD
Mol Med; 2006; 12(7-8):171-9. PubMed ID: 17088949
[TBL] [Abstract][Full Text] [Related]
9. METH-2 silencing and promoter hypermethylation in NSCLC.
Dunn JR; Panutsopulos D; Shaw MW; Heighway J; Dormer R; Salmo EN; Watson SG; Field JK; Liloglou T
Br J Cancer; 2004 Sep; 91(6):1149-54. PubMed ID: 15328519
[TBL] [Abstract][Full Text] [Related]
10. The regulation of aggrecanase ADAMTS-4 expression in human Achilles tendon and tendon-derived cells.
Corps AN; Jones GC; Harrall RL; Curry VA; Hazleman BL; Riley GP
Matrix Biol; 2008 Jun; 27(5):393-401. PubMed ID: 18387286
[TBL] [Abstract][Full Text] [Related]
11. Methyl jasmonate abolishes the migration, invasion and angiogenesis of gastric cancer cells through down-regulation of matrix metalloproteinase 14.
Zheng L; Li D; Xiang X; Tong L; Qi M; Pu J; Huang K; Tong Q
BMC Cancer; 2013 Feb; 13():74. PubMed ID: 23394613
[TBL] [Abstract][Full Text] [Related]
12. Loss of pigment epithelium derived factor expression in glioma progression.
Guan M; Yam HF; Su B; Chan KP; Pang CP; Liu WW; Zhang WZ; Lu Y
J Clin Pathol; 2003 Apr; 56(4):277-82. PubMed ID: 12663639
[TBL] [Abstract][Full Text] [Related]
13. ADAMTS-7, a direct target of PTHrP, adversely regulates endochondral bone growth by associating with and inactivating GEP growth factor.
Bai XH; Wang DW; Kong L; Zhang Y; Luan Y; Kobayashi T; Kronenberg HM; Yu XP; Liu CJ
Mol Cell Biol; 2009 Aug; 29(15):4201-19. PubMed ID: 19487464
[TBL] [Abstract][Full Text] [Related]
14. Aberrant promoter hypermethylation of the CHFR gene in oral squamous cell carcinomas.
Baba S; Hara A; Kato K; Long NK; Hatano Y; Kimura M; Okano Y; Yamada Y; Shibata T
Oncol Rep; 2009 Nov; 22(5):1173-9. PubMed ID: 19787237
[TBL] [Abstract][Full Text] [Related]
15. Decreased expression of ADAMTS-1 in human breast tumors stimulates migration and invasion.
Freitas VM; do Amaral JB; Silva TA; Santos ES; Mangone FR; Pinheiro Jde J; Jaeger RG; Nagai MA; Machado-Santelli GM
Mol Cancer; 2013 Jan; 12():2. PubMed ID: 23289900
[TBL] [Abstract][Full Text] [Related]
16. Expression of ADAMTS-1, -4, -5 and TIMP-3 in normal and multiple sclerosis CNS white matter.
Haddock G; Cross AK; Plumb J; Surr J; Buttle DJ; Bunning RA; Woodroofe MN
Mult Scler; 2006 Aug; 12(4):386-96. PubMed ID: 16900752
[TBL] [Abstract][Full Text] [Related]
17. Expression of vasohibin, an antiangiogenic factor, in human choroidal neovascular membranes.
Wakusawa R; Abe T; Sato H; Yoshida M; Kunikata H; Sato Y; Nishida K
Am J Ophthalmol; 2008 Aug; 146(2):235-243. PubMed ID: 18486097
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of ADAMTS-1, -4, and -5 in the trabecular meshwork.
Keller KE; Bradley JM; Acott TS
Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5769-77. PubMed ID: 19553617
[TBL] [Abstract][Full Text] [Related]
19. IL-1β down-regulates ADAMTS-13 mRNA expression in cells of the central nervous system.
Frentzou GA; Bradford C; Harkness KA; Haddock G; Woodroofe MN; Cross AK
J Mol Neurosci; 2012 Feb; 46(2):343-51. PubMed ID: 21732076
[TBL] [Abstract][Full Text] [Related]
20. Renal ischemia reperfusion inhibits VEGF expression and induces ADAMTS-1, a novel VEGF inhibitor.
Basile DP; Fredrich K; Chelladurai B; Leonard EC; Parrish AR
Am J Physiol Renal Physiol; 2008 Apr; 294(4):F928-36. PubMed ID: 18272597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
